Abstract:beta-Arrestins are key negative regulators and scaffolds of G protein-coupled receptor (GPCR) signalling. beta-Arrestin1 and beta-arrestin2 preferentially bind to the phosphorylated GPCRs in response to agonist stimulation, resulting in receptor internalization and desensitization. The critical roles of GPCR kinases (GRKs)-catalyzed receptor phosphorylation and interaction of beta-arrestins with the phosphorylated receptor in receptor internalization are well established. However, emerging evidence suggests that an agonist-stimulated internalization mechanism that is independent of receptor phosphorylation may also be employed in some cases, although the molecular mechanism for the phosphorylation-independent GPCR internalization is not clear. The current study investigated the role of receptor phosphorylation and the involvement of different beta-arrestin subtypes in agonist-induced delta-opioid receptor (DOR) internalization in HEK293 cells. Results from flow cytometry, fluorescence microscopy, and surface biotin labelling experiments showed that elimination of agonist-induced DOR phosphorylation by mutation GRK binding or phosphorylation sites only partially blocked agonist-induced receptor internalization, indicating the presence of an agonist-induced, GRK-independent mechanism for DOR internalization. Fluorescence and co-immunoprecipitation studies indicated that both the wild-type DOR and the phosphorylation-deficient mutant receptor could bind and recruit beta-arrestin1 and beta-arrestin2 to the plasma membrane in an agonist-stimulated manner. Furthermore, internalization of both the wild-type and phosphorylation-deficient receptors was increased by overexpression of either type of beta-arrestins and blocked by dominant-negative mutants of beta-arrestin-mediated internalization, demonstrating that both phosphorylation-dependent and -independent internalization require beta-arrestin. Moreover, double-stranded RNA-mediated interference experiments showed that either beta-arrestin1 or beta-arrestin2 subtype-specific RNAi only partially inhibited agonist-induced internalization of the wild-type DOR. However, agonist-induced internalization of the phosphorylation-deficient DOR was not affected by beta-arrestin1-specific RNAi but was blocked by RNAi against beta-arrestin2 subtype. These data indicate that endogenous beta-arrestin1 functions exclusively in the phosphorylation-dependent receptor internalization, whereas endogenous beta-arrestin2, but not beta-arrestin1, is required for the phosphorylation-independent receptor internalization. These results thus provide the first evidence of different requirement for beta-arrestin isoforms in the agonist induced phosphorylation-dependent and -independent GPCR internalization.

Heterologous Activation of Protein Kinase C Stimulates Phosphorylation of Δ-Opioid Receptor at Serine 344, Resulting in Β-Arrestin- and Clathrin-mediated Receptor Internalization

Inhibition of SNAP-25 Phosphorylation at Ser187 is Involved in Chronic Morphine-induced Down-regulation of SNARE Complex Formation

Identification of G protein-coupled receptor kinase 2 phosphorylation sites responsible for agonist-stimulated δ-opioid receptor phosphorylation

β-Arrestin1 and β-arrestin2 are differentially required for phosphorylation-dependent and -independent internalization of δ-opioid receptors: Roles of phosphorylation and different β-arrestins in DOR endocytosis

REGULATION OF OPIOID RECEPTOR SIGNAL TRANSDUCTION VIA BETA-ARRESTINS

Endogenous δ-Opioid and ORL1 Receptors Couple to Phosphorylation and Activation of p38 MAPK in NG108-15 Cells and This Is Regulated by Protein Kinase A and Protein Kinase C

Beta-arrestin1 and beta-arrestin2 are differentially required for phosphorylation-dependent and -independent internalization of delta-opioid receptors.

Serine 363 of the Δ-Opioid Receptor is Crucial for Adopting Distinct Pathways to Activate ERK1/2 in Response to Stimulation with Different Ligands

Post‐endocytic Fates of Δ‐opioid Receptor Are Regulated by GRK2‐mediated Receptor Phosphorylation and Distinct Β‐arrestin Isoforms

Agonist-induced Formation of Opioid Receptor-G Protein-coupled Receptor Kinase (Grk)-Gβγ Complex on Membrane is Required for GRK2 Function in Vivo

Direct binding of β-arrestins to two distinct intracellular domains of the δ opioid receptor

Agonist-induced Endocytosis and Receptor Phosphorylation Mediate Resensitization of Dopamine D(2) Receptors.

Activation of N-methyl-D-aspartate receptor attenuates acute responsiveness of delta-opioid receptors.

Molecular Modeling on Kappa Opioid Receptor and Its Interaction with Nonpeptide Kappa Opioid Agonists

EGF transregulates opioid receptors through EGFR-mediated GRK2 phosphorylation and activation

Direct binding of β-arrestins to two distinct intracellular domains of the δ opioid receptor: Interaction of δ opioid receptor with β-arrestins

N-Methyl-D-Aspartate Attenuates Opioid Receptor-Mediated G Protein Activation and This Process Involves Protein Kinase C

Direct and Differential Interaction of Beta-Arrestins with the Intracellular Domains of Different Opioid Receptors.

Phosphorylation State of Mu-Opioid Receptor Determines the Alternative Recycling of Receptor Via Rab4 or Rab11 Pathway

Direct and Differential Interaction of β-Arrestins with the Intracellular Domains of Different Opioid Receptors

Involvement of cAMP/cAMP-dependent protein kinase signaling pathway in regulation of Na+,K+-ATPase upon activation of opioid receptors by morphine.